Expanded Access to Veliparib

Clinical trial NCT03123211 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03123211
Sponsor: AbbVie
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian Cancer Patients Requiring Veliparib Suspension Formulation

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.